Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164 - Wikidata - wikimedia - TriplyDB

Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164

Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164

http://www.wikidata.org/entity/Q33627325

about

Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin Wound Healing Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicine Immunobiology of fibrin-based engineered heart tissue Vital roles of stem cells and biomaterials in skin tissue engineering Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation.Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.Tailoring the degradation rates of thermally responsive hydrogels designed for soft tissue injection by varying the autocatalytic potential.In vitro selection technologies to enhance biomaterial functionality.Designer Hydrogels for Precision Control of Oxygen Tension and Mechanical Properties Growth Factor-Mediated Migration of Bone Marrow Progenitor Cells for Accelerated Scaffold Recruitment Computational Model-Based Analysis of Strategies to Enhance Scaffold Vascularization.Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis.Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair.Mesenchymal stem cell growth on and mechanical properties of fibrin-based biomimetic bone scaffolds.Engineered microenvironments for synergistic VEGF - Integrin signalling during vascularization.Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution.It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration.Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells.Mechanotransduction and Growth Factor Signalling to Engineer Cellular Microenvironments.Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.Synergistic growth factor microenvironments.In vitro evaluation of gel-encapsulated adipose derived stem cells: Biochemical cues for in vivo peripheral nerve repair.The evolution of fibrin-specific targeting strategies.The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells.A computational analysis of pro-angiogenic therapies for peripheral artery disease.Local Release of VEGF Using Fiber Mats Enables Effective Transplantation of Layered Cardiomyocyte Sheets.Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model.EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering.Therapeutic neovascularization promoted by injectable hydrogels.

P2860

Q26798452-367BB682-9692-4004-86F9-EE45FDCCA058 Q26829783-7E89F290-E898-412E-AE4D-C6270D3F9BDE Q27301288-3AE79F16-4B86-42C0-9D01-890F3ADC5FF4 Q28085048-56BF76C2-207B-4CC6-9A56-F5B272D46201 Q33758370-D4D1B97D-2B1D-4FD5-AF19-1119DEA95220 Q34140406-BB49197E-820B-49D6-83AA-A5D5D816DE7C Q34245084-7EF7CC46-33FD-4CA1-BA1B-6666355010DE Q35047445-DF4E91C8-F29C-4AEB-B515-EDEFB3CAD6DE Q35516791-BCDD6BEC-F9A2-4FC7-8C42-C5E7A2E4A27C Q36020230-44AF070D-19EF-468E-9D71-6C8F98C3FABD Q36362019-1CCAD0EF-3CEA-41DC-9A78-8B59F95299EB Q37102083-BC8A204B-8B0D-4CF6-AEB4-02D9581CAA27 Q37485219-14FD6445-9ADC-49F2-9BBB-27A7765D810B Q38268460-D84A1062-C598-495F-98CD-72BAD6E6311C Q38530142-13D0BCC9-D6E3-4F79-8F51-1940F3B50F77 Q39568614-07D6A14E-43DB-427B-8207-C4CD9FFB8A63 Q42315903-A9C685D8-C5B4-4D14-8050-2D91FEC76CD0 Q45872982-32379427-35CC-4A65-8F1E-1B996FB9EBDC Q46894342-815A1477-1BAF-4879-9B7E-7418B57C3B2D Q47713030-48857B59-A7C2-413A-852B-A955D125EC15 Q47814370-D9800E19-585E-4CC1-A540-091FA4E48D53 Q48197251-9D801867-1844-4768-BC5E-CFA4811345AD Q48313017-EF01EAD9-A9C0-4A45-8322-76093A9FB388 Q48361619-C109A5D1-CEA1-4DBA-91C0-DE6D9E332C0A Q49265874-6EC9A8EB-24C6-4024-B17F-063715080574 Q49733672-72EEFA25-3F23-4AFE-B05F-63C4A13D727F Q50071368-66785656-6F1B-42E5-8627-29F0FA44E231 Q50862215-8286F8FB-2EAA-46E8-8938-B9DDDABE84D7 Q53497534-07D58C6C-602D-4D2E-9CBB-88AFA08661D1 Q55004289-BD31757C-093B-472D-9C92-7A02F75FCD8A Q55435403-10405E34-E50C-47A8-92B2-2ABB4039D25F Q55638524-BDF390D6-528D-49EC-A990-40D9EF4AA9F9

P2860

Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164

http://www.wikidata.org/entity/Q33627325

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@ast

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@en

type

label

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@ast

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@en

prefLabel

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@ast

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@en

P1433

Q33627325-F5588CBF-91C1-4D25-9400-67B3049CF586

P1476

Q33627325-DBC83AF8-385E-44E5-B518-884DFFC79AA1

P2093

Q33627325-20B20D8A-D995-4DC4-8277-813139952FE6

Q33627325-23D3AD0E-3E61-4157-811C-149920336E0D

Q33627325-2FDED26F-53F6-4AA8-8793-10E460E0D5A0

Q33627325-338848DB-1B9E-4D3D-9A47-FF7754E1726B

Q33627325-42570FDB-57AA-4667-A0D6-CDBF0F123ECE

Q33627325-5F34A4A7-FCE5-485D-9788-2248F1511781

Q33627325-5FBE1D0F-1F1F-476B-86EF-5CEC2F4157C4

Q33627325-B993A0F7-5707-4B93-822F-AE2F6A32DC1B

Q33627325-FE98DCDE-6BF8-4486-A83A-AE1BB9657C92

P2860

Q33627325-133273D5-04B6-460A-822E-3C5F0B50F657

Q33627325-188E2F2E-06D8-43E6-8E4F-D5D853FC53A1

Q33627325-24048E12-B937-4CD5-8983-92F527188244

Q33627325-24F40907-E61A-4AB7-A0C6-BDF00C70CE7E

Q33627325-3743FE4E-156A-467F-AE63-1E5281CFE2C1

Q33627325-3ADEFFDA-8A12-4B43-B86A-A63294C06841

Q33627325-3E557BBF-BE0D-43D0-B237-60EA25458793

Q33627325-3ED0287C-CF77-48D3-B0B9-D0060ABEF360

Q33627325-5180D19A-B897-41A1-BAEC-857E2D913C2A

Q33627325-5446FCD0-5BD4-419E-BDCD-E34315CED1EA

P304

Q33627325-CD9170CF-E966-4FA3-8682-CF4C306A1964

P31

Q33627325-F3189CCC-0A06-446C-A6F3-591176BCA6D4

P356

Q33627325-AEF1B2DD-D3B0-47E6-8E84-269354596E26

P407

Q33627325-4069D387-A967-4853-B983-DBA0A09039C8

P433

Q33627325-E3F10AC7-ED52-4C32-87FF-16B2EEE882D1

P478

Q33627325-5D1BA80C-DB77-4FC0-ABF2-55D378A0C3A5

P50

Q33627325-40C7D760-3204-4767-97CF-AC42880C212D

Q33627325-561E21C0-423B-4889-8B5E-A45D6ACFECB5

Q33627325-783D62B4-A1EE-4035-9BED-E88403D6875B

Q33627325-90F2E2AC-71C1-4E53-9C06-9D0E1915A8CA

Q33627325-E049C373-0928-4A35-B91A-AB099D70120C

Q33627325-EA8D6869-A3DC-4A34-995F-0D9C3C928852

P577

Q33627325-991641F5-8220-4CAE-A3B9-E2B01F0347DC

P5875

Q33627325-A90A7FB0-D058-44AB-8F95-C502B91702DF

P698

Q33627325-27D6DF99-32A5-4BB5-9920-B57682D341D1

P932

Q33627325-F1F7962A-49B1-4B6B-AAA6-467138A2697F

P356

PNAS.1404605111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Long-lasting fibrin matrices e ...... elivery of recombinant VEGF164

@en

P2093

Anna Hofmann

http://www.w3.org/2001/XMLSchema#string

Heinz Redl

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Marschall

http://www.w3.org/2001/XMLSchema#string

Joachim Hartinger

http://www.w3.org/2001/XMLSchema#string

Kristen M Lorentz

http://www.w3.org/2001/XMLSchema#string

Rainer Mittermayr

http://www.w3.org/2001/XMLSchema#string

Remo A Largo

http://www.w3.org/2001/XMLSchema#string

Roberto Gianni-Barrera

http://www.w3.org/2001/XMLSchema#string

Veronica Sacchi

http://www.w3.org/2001/XMLSchema#string

P2860

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

Molecular mechanisms and clinical applications of angiogenesis

Mouse model of angiogenesis

Fibrin-embedded administration of VEGF plasmid enhances skin flap survival.

Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.

Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension.

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.

Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.

The shunt problem: control of functional shunting in normal and tumour vasculature.

Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.

P304

6952-6957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1404605111

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey A. Hubbell

Mikaël M Martino

Susanne Wolbank

P577

2014-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261956576

http://www.w3.org/2001/XMLSchema#string

P698

24778233

http://www.w3.org/2001/XMLSchema#string

P932

4024904

http://www.w3.org/2001/XMLSchema#string